LetterLetter
Urinary N-telopeptide as a Biomarker of Disease Activity in Patients with Chronic Nonbacterial Osteomyelitis Who Have Not Received Bisphosphonates
Alexandra Perkins, Anne M. Stevens, Polly J. Ferguson and Yongdong Zhao
The Journal of Rheumatology December 2020, 47 (12) 1842-1844; DOI: https://doi.org/10.3899/jrheum.191098
Alexandra Perkins
1University of Washington School of Medicine, Seattle, Washington;
MD, MPHAnne M. Stevens
2Seattle Children’s Hospital, Seattle, Washington, and Janssen Research & Development, LLC, Spring House, Pennsylvania;
MD, PhDPolly J. Ferguson
3University of Iowa Carver College of Medicine, Iowa City, Iowa;
MDYongdong Zhao
4Seattle Children’s Hospital and Clinical and Translational Research Center, Seattle, Washington,
USA.
MD, PhD
REFERENCES
- 1.↵
- 2.↵
- 3.↵
- 4.↵
- 5.↵
- Sato J,
- Hasegawa K,
- Tanaka H,
- Morishima T
- 6.↵
- Ju HS,
- Leung S,
- Brown B,
- Stringer MA,
- Leigh S,
- Scherrer C,
- et al.
- 7.↵
- Hu HM,
- Du HW,
- Cui JW,
- Feng DQ,
- Du ZD
- 8.↵
- Thomaidou A,
- Chatziioannou AC,
- Deda O,
- Benaki D,
- Gika H,
- Mikros E,
- et al.
In this issue
The Journal of Rheumatology
Vol. 47, Issue 12
1 Dec 2020
Urinary N-telopeptide as a Biomarker of Disease Activity in Patients with Chronic Nonbacterial Osteomyelitis Who Have Not Received Bisphosphonates
Alexandra Perkins, Anne M. Stevens, Polly J. Ferguson, Yongdong Zhao
The Journal of Rheumatology Dec 2020, 47 (12) 1842-1844; DOI: 10.3899/jrheum.191098





